中 / EN

China

234 entries
July 2026

Chinese Rehabilitation Association Sets July Workshop on Closed-Loop EEG-TMS

The Chinese Association of Rehabilitation Medicine will hold a workshop on EEG-driven closed-loop TMS in Guangzhou, southern China, on July 17, 2026, staged under its Naoke China (脑客中国) series and run by its committee on brain function monitoring and modulation in rehabilitation. The technique reads EEG in real time and triggers a TMS pulse when a target brain state appears, a 'brain-state-dependent stimulation' approach that pairs the spatial precision of TMS with the temporal resolution of EEG, and the program is built around moving BCI work out of the laboratory into neurorehabilitation and the precision diagnosis of brain disorders. Shenzhen Yingchi Technology, a subsidiary of Hanix United, is among the supporting organizations, and registration closes on July 17.

Beihang and Tsinghua Team Fuses EEG, Video and Motion to Flag VR Cybersickness

Researchers at Beihang University and Tsinghua University in Beijing built a multimodal contrastive learning framework that pairs EEG with synchronized video and motion data to detect cybersickness in virtual reality, representing the EEG as a connectivity graph and using an attention-based encoder to map the video and motion streams onto the same structure. Fusing all three signals separated cybersick from non-cybersick states more cleanly than any single modality or pair, and the model automatically pruned prefrontal connections unrelated to cybersickness. The setup used mBrainTrain's Smarting PRO 32-channel wireless EEG system and a Pico 4 Ultra headset, with 29 healthy adults navigating a VR scene under their own control.

Study Involving Hangzhou Dianzi University Achieves 1024-Channel Recording in Pig Cortex

A collaborative study involving authors from Hangzhou Dianzi University and other institutions developed a three-dimensional helical stretchable neural probe and achieved 1024-channel signal acquisition in the pig cerebral cortex. The researchers also report single-unit recordings with long-term stability in the mouse deep brain, while flexible planar microelectrode arrays recorded subcutaneous EMG signals in mice. The probe is fabricated using planar microfabrication followed by thermally driven helical shaping, expanding wiring space and accommodating tissue motion. Mechanical simulations and cyclic stretching tests examined strain mitigation and electrochemical stability, respectively. These device and animal results do not establish long-term performance in humans.

Beijing Tongren Hospital Registers Observational Study of Clinical Needs for Invasive Visual BCI

The study involves no implant and tests no device. It asks 50 adults with acquired blindness what existing assistive devices get wrong, and what they would want from a vision-restoration implant. Outcomes span demographics and economics, quality of life, clinical features, satisfaction with current aids, and design requirements for an invasive visual brain-computer interface. Participants must be at least 18, have only weak or no light perception in both eyes, and have lost their sight after birth; congenital blindness is excluded.

China's MIIT and Six Ministries Issue BCI Industry Development Guidelines

Seven Chinese ministries led by MIIT issued guidelines targeting breakthroughs in core BCI technologies by 2027 — including electrodes, chips, and integrated devices at internationally competitive levels — with accelerated deployment in manufacturing, healthcare, and consumer markets. By 2030, the plan calls for cultivating 2–3 globally influential BCI companies and building an internationally competitive industry ecosystem.

Bio-Inspired Methods Target EEG Robustness

A perspective review published in Computers in biology and medicine examines EEG non-stationarity across sessions, people, and recording conditions. It asks whether mechanisms that help the brain maintain functional stability can improve the robustness of brain-computer interface models. The review covers synaptic plasticity, homeostatic regulation, neural oscillations, and spiking representations, comparing bio-inspired approaches with conventional machine learning and transfer learning. It also considers hybrid designs that combine biologically grounded mechanisms with artificial neural networks. The author proposes operational definitions for bio-inspired, bio-plausible, and bio-realistic modeling, together with a minimum specification for continual EEG benchmarks. Because direct EEG evidence remains limited for several proposed mechanisms, the review stresses the need to distinguish empirical findings from hypotheses and future research directions.
June 2026

Injectable Antifouling Adhesive Hydrogel Enables Robust Neural Interfaces for Stable ECoG Recording

Researchers propose an injectable, in-situ-gelling multifunctional hydrogel to address the failure modes of micro-ECoG cortical recording — dural barrier disruption, cortical micromotion that weakens device-tissue coupling, and biofouling that triggers a foreign-body response. Combining dopamine-grafted sodium alginate with branched polyethyleneimine, the hydrogel forms a quasi-zwitterionic network that resists nonspecific protein adsorption and provides catechol-mediated wet adhesion, gelling rapidly under surgical-compatible conditions through dual macromolecular crosslinking without diffusible small-molecule monomers. Integrated with a 128-channel flexible micro-ECoG mesh array, the platform reduced glial activation and fibrotic encapsulation and preserved stable, high-fidelity cortical recording over the 3-week early chronic period. The authors say co-designing barrier repair, interface adhesion and antifouling in a single material can improve long-term function.

Multi-View Contrastive Learning Improves Cross-Subject ERP Classification

MVCLDG combines raw EEG and Hilbert-derived phase information with domain-alignment and contrastive-learning constraints to improve classification across unseen users. It outperformed baseline and representative domain-generalization methods on a public error-related-negativity dataset and a semantic-syntactic-violation dataset without target-domain adaptation; ablation and activation-map analyses supported the contribution and neurophysiological plausibility of its components.

Anhui Hospital Registers 60-Patient BCI Trial for Post-Stroke Motor Dysfunction

The trial compares motor imagery BCI plus standard rehabilitation against standard rehabilitation alone in stroke patients with hemiplegia, tracking limb motor function and daily living ability. It planned to enroll 60 participants, 30 per arm, with the first participant enrolled on August 10, 2022; the registry now lists the study as completed. Beyond motor scales, the primary outcomes include functional connectivity and a lateralization index measured with fNIRS, probing brain-network changes rather than behavior scores alone.

Brain-to-Image Framework Splits Shared and Personal Features to Cut Calibration Data

Researchers at Lanzhou University, Zhejiang University, the University of Hong Kong and Sun Yat-sen University have built MindShow, a unified generative framework that reconstructs images from fMRI at cohort level rather than one subject at a time. A hierarchically conditioned mixture-of-experts encoder separates population-shared latent representations from subject-specific neural traits, so a new subject can be adapted with limited calibration data; a gated Perceiver bottleneck maps fMRI features into fixed-size image and text tokens, an optimal transport loss aligns them with a pretrained vision-language model, and a frozen diffusion model renders the image. The authors report better high-level reconstruction metrics with competitive structural fidelity, in a study published in Medical Image Analysis on June 20, 2026.

OYMotion and MicroPort NeuroScientific Partner on Endovascular BCI Rehab System

OYMotion and MicroPort NeuroScientific signed a strategic cooperation agreement on May 28, 2026 to jointly develop an interventional brain-computer interface rehabilitation system. The first product will be a multi-channel endovascular BCI that threads a signal-recording stent through the blood vessels to a target brain region, capturing intracranial electrical activity without opening the skull. MicroPort NeuroScientific will build the BCI system as a whole and OYMotion the limb side, with the pair targeting medical rehabilitation and human-machine interaction.

Neuracle Registers UDI for Implantable EEG Electrode Kit

Neuracle Medical Technology (Shanghai) Co., Ltd. registered an Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. The model is K1014-15, and the registration certificate number is 国械注准20263120536. The listed kit includes a cortical electrode, a blank electrode, and surgical and fixation components. It is both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The system also includes an implant, an EEG transceiver, a pneumatic glove device, and software. This entry identifies the product and its composition; it does not establish the complete system's registration status or clinical performance.

Neuracle Registers UDI for NEO-M Pro Hand Motor Function Compensation System

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the Implantable Brain-Computer Interface Hand Motor Function Compensation System in the NMPA Medical Device Unique Identification database. Its model is NEO-M Pro, and its registration certificate number is 国械注准20263120537. The description lists a BCI implant, an implantable EEG electrode kit, a disposable surgical tool kit, an EEG signal transceiver, a pneumatic glove device, and three software products, each with release version 1.0. The entry provides product identification and composition information; UDI registration itself should not be interpreted as validation of clinical efficacy or safety.

Neuracle Registers UDI for K1014-25 Implantable EEG Electrode Kit

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the K1014-25 Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120536. According to the company's registered description, the kit includes a cortical electrode, a blank electrode, and associated tools and fixation components. It is both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The entry also lists the system's EEG transceiver, pneumatic glove device, and software. It identifies the kit and its relationship to the system; UDI registration itself does not validate clinical efficacy or safety.

Neuracle Registers UDI for K1014-35 Implantable EEG Electrode Kit

Neuracle Medical Technology (Shanghai) Co., Ltd. registered the K1014-35 Implantable EEG Electrode Kit in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120536. The company's description lists a cortical electrode, a blank electrode, and associated tools and fixation components. It describes the kit as both a product with its own registration certificate and a component of an implantable brain-computer interface hand motor function compensation system. The notes also list an EEG transceiver, a pneumatic glove device, and software within that system. The kit's UDI entry alone does not confirm the complete system's registration status or clinical performance.

Neuracle Registers UDI for NEO-M Hand Motor Function Compensation System

Neuracle registered the NEO-M Implantable Brain-Computer Interface Hand Motor Function Compensation System in the NMPA Medical Device Unique Identification database. Its registration certificate number is 国械注准20263120537. According to the company's description, the system includes a BCI implant, an implantable EEG electrode kit, a disposable surgical tool kit, an EEG signal transceiver, a pneumatic glove device, and EEG decoding, medical testing, and clinical management software. All three software products have release version 1.0. The entry identifies the product and its components; UDI registration itself does not validate clinical efficacy or safety.

Anhui Splits BCI Work Across Three Cities

The General Office of China's Anhui Provincial People's Government issued the Action Plan for Accelerating Brain-Computer Interface Technology and Industry Development in Anhui (2026-2030) on June 15, 2026, document number Wan Zheng Ban Mi [2026] No. 24. Its spatial layout assigns Hefei the role of innovation origination and talent attraction, Bengbu the fabrication and validation of key components on the strength of its smart sensor industry plus a new Longhu Laboratory, and Wuhu clinical translation through a national regional medical centre and a brain science institute at Wannan Medical College. The first main task backs the University of Science and Technology of China in leading a research institute with Chinese Academy of Sciences partners. Targets fall in 2028 rather than 2027, covering at least ten application scenarios, three approved invasive clinical trials, five systems and three backbone firms.

NeuroXess Says Two Paralyzed Patients Played Brain-Controlled Chess 800 km Apart

NeuroXess said two people with high-level paralysis played chess against each other across about 800 kilometers, between Shanghai and Nanchang in eastern China, using its "Triple-Full" (三全) brain-computer interface: one selected and placed pieces on a virtual board by thought, with the commands relayed in real time to a robot stand-in that moved the pieces at the other end, where the second participant gripped physical pieces through a brain-controlled exoskeleton glove. The company said the first participant was implanted at Huashan Hospital, Fudan University, in October 2025, moved a cursor by thought on the fifth day after surgery and reached 5.2 bits per second after 17 days of training, while the second was implanted at the First Affiliated Hospital of Nanchang University in December 2025 and was eating, drinking and writing with a brain-controlled exoskeleton one month after surgery. The outcomes come from the vendor's own account and have not been validated in peer-reviewed publication.

China's Neuracle Files for Shanghai IPO, Seeking RMB 2.5 Billion

The Shanghai Stock Exchange accepted an IPO application from Neuracle, which is seeking RMB 2.5 billion for BCI product development, industrialization and working capital. The filing shows an established non-invasive neurophysiology equipment business alongside invasive products that still require clinical, regulatory and commercialization spending. Acceptance starts the review process and is not approval to list.

Northwestern Polytechnical University Registers BCI Stroke Rehabilitation Trial With 4 Arms

A newly registered trial tests a brain-computer interface in post-stroke rehabilitation across 4 parallel arms: full cross-domain (emotion-cognition-motor) adaptive training, integrated cognitive and motor task training, single-dimension motor training, and conventional rehabilitation. Each arm plans 22 participants, 88 in total. It enrolls patients aged 30 to 80 with a first cerebral infarction or hemorrhage 3 months to 1 year earlier, unilateral hemiplegia, and upper-limb Brunnstrom stage II to IV. The primary outcome is a motor function score; secondary outcomes include EEG motor imagery event-related synchronization/desynchronization, prefrontal theta/alpha power ratio, and EEG-fNIRS coupling.

Suzhou Hospital Registers Closed-Loop BCI Trial Using fNIRS and rTMS for Female Overactive Bladder

Women with overactive bladder often rely on drugs and behavioral training, with limited relief. A newly registered trial at The First Affiliated Hospital of Soochow University takes a different route: patients perform a task while functional near-infrared spectroscopy reads prefrontal brain activity, and an algorithm decides when to deliver transcranial magnetic stimulation, closing the loop. The interventional, parallel-design trial plans to enroll 66 women aged 18 to 75, 33 in the experimental arm and 33 in a control arm that receives open-loop sham stimulation, with the overactive bladder symptom score as the primary endpoint. No device model or results are disclosed in the registration, and recruitment has not yet started.
May 2026

Tianjin Plans 10bn Yuan BCI Fund Cluster

The General Office of China's Tianjin Municipal People's Government issued the Action Plan for Promoting Innovative Development of Brain-Computer Interfaces in Tianjin (2026-2030), document number Jin Zheng Ban Fa [2026] No. 8, dated May 26, 2026 and released on May 28. All product targets sit on the non-invasive track, while invasive systems are covered only by milestones for entering registration trials and winning market approval. By 2027 Tianjin wants two to three national-level innovation platforms, more than five non-invasive products in clinical use, more than ten new products across elderly care, education, entertainment, smart living and advanced manufacturing, 50 innovative firms, one to two national standards, and three to five industry funds. By 2030 it targets more than ten non-invasive products in large-scale clinical use, market approval for invasive products, and a fund cluster exceeding 10 billion yuan.

ChiCTR Registers Trial of Motor Imagery BCI for Lower-Limb Stroke Rehab

The Chinese Clinical Trial Registry (ChiCTR) has logged a study of how brain-computer interface training built on a motor imagery paradigm affects lower-limb motor function in stroke patients. Registered on May 28, 2026 as ChiCTR2600125562, the trial is recruiting; design, sample size and sponsor are absent from the record carried by the WHO International Clinical Trials Registry Platform (ICTRP) and must be read from the original ChiCTR entry.

Shanghai Trial to Test BCI-Driven Lower Limb Exoskeleton in 60 Stroke Patients

The randomized controlled trial plans to enroll 60 patients with lower limb motor impairment after stroke, with the intervention group receiving BCI-assisted exoskeleton rehabilitation training and the control group conventional walking training. Primary outcomes include lower limb surface electromyography, lower limb motor function, the Modified Barthel Index, a balance scale and functional ambulation, testing whether a BCI-driven exoskeleton adds functional benefit over conventional gait training. Punan Hospital, Pudong New Area, Shanghai is the sponsor, with first enrolment set for May 30, 2026. The trial is registered with the Chinese Clinical Trial Registry (ChiCTR) under number ChiCTR2600125531, with a registration date of May 28, 2026, and recruitment has not yet started.

Xuanwu Hospital Registers BCI Rehabilitation Trial Enrolling 58 Stroke Patients

The randomized controlled trial plans to enroll 58 patients with upper limb motor dysfunction after stroke. The test group will receive feedback-based rehabilitation training through brain-computer interface interaction, while the control group will undergo traditional upper limb circular motion training. The primary outcome is the Fugl-Meyer Motor Assessment-Upper Extremity (FMA-UE), with secondary outcomes covering motor function, daily living activities, quality of life and neurophysiological measures including EEG, transcranial magnetic stimulation and fNIRS. The trial was prospectively registered, with first enrolment set for June 1, 2026, and recruitment has not yet started.

Jiangxi Sets 10-Day Clock on BCI Ethics Review

The Jiangxi Provincial Health Commission in eastern China issued Guidelines for Ethics Review of Brain-Computer Interface Clinical Research Projects on May 26, 2026, document number Gan Wei Ke Jiao Fa [2026] No. 8, providing implementing detail for the mutual recognition mechanism proposed in the province's November 2025 BCI measures. For multicentre projects the lead institution's ethics committee conducts the first full review; participating institutions should finish within 10 working days of receiving complete materials and examine only local research conditions, staff qualifications and the informed-consent process; and the lead institution must file with the provincial medical ethics expert committee within 10 working days. Invasive projects treating neurological or psychiatric disease need provincial committee review within 20 working days, with an opinion issued within a further seven.
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About